by GlobeNewsWire | Jun 28, 2016 | Globe Newswire
Positive trends from BRIGHT-SC proof-of-concept study – study to continueSOLUTION study with Sollpura completed patient screening ahead of schedule – data in 2016First patients screened in Phase 3 CHABLIS 7.5 study of blisibimod in seropositive lupus...
by GlobeNewsWire | Jun 28, 2016 | Globe Newswire
WATERTOWN, Mass., June 28, 2016 (GLOBE NEWSWIRE) — Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that it was...
by GlobeNewsWire | Jun 28, 2016 | Globe Newswire
MINNEAPOLIS, June 28, 2016 (GLOBE NEWSWIRE) — Sun BioPharma, Inc. (OTCPink:SNBP), a biopharmaceutical company developing therapeutics for the treatment of patients with pancreatic diseases, today announced sales of equity securities resulting in total proceeds...
by GlobeNewsWire | Jun 28, 2016 | Globe Newswire
Anxiety and Hyperactivity Benefit shown in FXS Children Study Investigator to Participate in Conference Call and Webcast Today at 9:00 a.m. ET RADNOR, Pa., June 28, 2016 (GLOBE NEWSWIRE) — Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company...
by GlobeNewsWire | Jun 28, 2016 | Globe Newswire
Rockville, MD, June 28, 2016 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer as well as autoimmune...